Global Kinetics Corporation
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Global Kinetics Corporation - overview
Established
2007
Location
-, -, Australia
Primary Industry
Medical Devices & Equipment
About
Founded in 2007 and based in Australia, Global Kinetics Corporation provides precise recording, quantification and reporting of movement symptoms of neurological disease.
Current Investors
Bioscience Managers, Brandon Capital Partners
Primary Industry
Medical Devices & Equipment
Sub Industries
Epidemiology
Website
www.globalkineticscorporation.com.au
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Global Kinetics Corporation - financials
| Fiscal Year Ended | Jun 30, 2016 | Jun 30, 2017 | Jun 30, 2018 | Jun 30, 2019 |
|---|---|---|---|---|
| Revenue (USD) | 661,653 | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - |
| EBITDA (USD) | (11,311,797) | - | - | - |
| Operating Income (USD) | (11,680,831) | - | - | - |
| Operating Margin | (1765.4%) | - | - | - |
| % EBITDA Margin | (1709.6%) | - | - | - |
| NET Income (USD) | (9,533,833) | - | - | - |
| % Net Margin | (1440.9%) | - | - | - |
Global Kinetics Corporation - employee data
Global Kinetics Corporation - key contacts
| Name | Position | Start Date | End Date | Vcard | Bio | ||
|---|---|---|---|---|---|---|---|
| CEO, President & Board Member | BM |
BM Board Member
Want to see more?
Request a demo for full access to this profile
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.